National Comprehensive Cancer Network

About NCCN

NCCN Global Programs – Asia

By Jorge Bacigalupo, Global Business Development Specialist, NCCN

The National Comprehensive Cancer Network® (NCCN®) is dedicated to improving high-quality, high-value cancer care around the globe, including through various collaborations to promote translations and adaptations of NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for use in Asia.

NCCN has a significantly active presence in Asia with more than 135,000 registered oncology professionals and more than 500,000 NCCN Guidelines® downloaded in 2015.



The graph above represents the top countries of registered users in Asia

Adaptations of the NCCN Guidelines are developed by the host country's oncology thought leaders in conjunction with NCCN Guidelines Panel Members. Modified NCCN Guidelines are developed to aid clinicians in determining appropriate and efficient avenues of care in the specified country.

NCCN is collaborating with Reno Medical to publish the regional adaptation of the NCCN Guidelines® for Non-Small Cell Lung Cancer (NSCLC) for use in Asia. This adaptation, the Asia Consensus Statement for NSCLC, is a manuscript designed to provide clinical resources for Asian specialists who are involved in the management of patients with NSCLC within the represented countries. NCCN expects the adaptation to be available in the first quarter of of 2017.

In addition to RENO Medical, NCCN collaborates with The Translational Research Informatics Center (TRI) Foundation for Biomedical Research and Innovation, under the supervision of the Japanese Society for Cancer, to translate the entire library of the NCCN Guidelines into Japanese.

To view the entire library of translations and adaptations of NCCN Guidelines for Asia, please visit

If you would like to learn more about translation or regional adaptations of the NCCN Guidelines or other NCCN Content as well as other international programming opportunities, please contact Jorge Bacigalupo,